SCHEMBL21561460

SCHEMBL21561460

CC[C@@H]1C[C@H](N)CCN(Cc2ccn3ncnc(Nc4ccc(Oc5ccn6ncnc6c5)c(C)c4)c23)C1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ERBB2 P04626 19/20 0.55
▸ EGFR P00533 17/20 0.55
▸ LCK P06239 2/20 0.50
▸ KDR P35968 1/20 0.50
▸ CIT O14578 1/20 0.49
▸ CHEK1 O14757 1/20 0.49
▸ GAK O14976 1/20 0.49
▸ STK10 O94804 1/20 0.49
▸ PRKD3 O94806 1/20 0.49
▸ ABL1 P00519 1/20 0.49
▸ FYN P06241 1/20 0.49
▸ YES1 P07947 1/20 0.49
▸ LYN P07948 1/20 0.49
▸ RET P07949 1/20 0.49
▸ HCK P08631 1/20 0.49
▸ SRC P12931 1/20 0.49
▸ PHKG2 P15735 1/20 0.49
▸ PRKCA P17252 1/20 0.49
▸ PRKACA P17612 1/20 0.49
▸ CSNK2A2 P19784 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21561484 0.91 EGFR (0.67) ERBB2EGFRLCKKDRAAK1
SCHEMBL21561455 0.88 ERBB2 (0.56) ERBB2EGFRLCKKDRCIT
SCHEMBL21561501 0.88 ERBB2 (0.56) ERBB2EGFRLCKKDRCIT
SCHEMBL21561454 0.88 ERBB2 (0.56) ERBB2EGFRLCKKDRCIT
SCHEMBL21561456 0.88 ERBB2 (0.56) ERBB2EGFRLCKKDRCIT
SCHEMBL21561451 0.88 ERBB2 (0.56) ERBB2EGFRLCKKDRCIT
SCHEMBL21561453 0.87 ERBB2 (0.51) ERBB2EGFRLCKKDR
SCHEMBL27444061 0.87 ERBB2 (0.51) ERBB2EGFRLCKKDR
SCHEMBL23096271 0.86 EGFR (0.57) ERBB2EGFRLCKKDRCIT
SCHEMBL21561457 0.86 EGFR (0.57) ERBB2EGFRLCKKDRCIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019214651-A1 PYRROLO[2,1-F][1,2,4]TRIAZINE DERIVATIVES SERVING AS SELECTIVE HER2 INHIBITORS AND APPLICATION THEREOF 南京明德新药研发有限公司 (CN) 2019-11-14 — — WO disclosed
Send feedback